Literature DB >> 31776265

Intact HIV Proviruses Persist in Children Seven to Nine Years after Initiation of Antiretroviral Therapy in the First Year of Life.

Mary Grace Katusiime1, Elias K Halvas2, Imogen Wright3, Kevin Joseph2, Michael J Bale4, Bronwyn Kirby-McCullough5, Susan Engelbrecht6, Wei Shao4,7, Wei-Shau Hu4, Mark F Cotton8, John W Mellors2, Mary F Kearney4, Gert U van Zyl1.   

Abstract

In adults starting antiretroviral therapy (ART) during acute infection, 2% of proviruses that persist on ART are genetically intact by sequence analysis. In contrast, a recent report in children treated early failed to detect sequence-intact proviruses. In another cohort of children treated early, we sought to detect and characterize proviral sequences after 6 to 9 years on suppressive ART. Peripheral blood mononuclear cells (PBMC) from perinatally infected children from the Children with HIV Early antiRetroviral (CHER) study were analyzed. Nearly full-length proviral amplification and sequencing (NFL-PAS) were performed at one time point after 6 to 9 years on ART. Amplicons with large internal deletions were excluded (<9 kb). All amplicons of ≥9 kb were sequenced and analyzed through a bioinformatic pipeline to detect indels, frameshifts, or hypermutations that would render them defective. In eight children who started ART at a median age of 5.4 months (range, 2.0 to 11.1 months), 733 single NFL-PAS amplicons were generated. Of these, 534 (72.9%) had large internal deletions, 174 (23.7%) had hypermutations, 15 (1.4%) had small internal deletions, 3 (1.0%) had deletions in the packaging signal/major splice donor site, and 7 (1.0%) were sequence intact. These 7 intact sequences were from three children who initiated ART after 2.3 months of age, one of whom had two identical intact sequences, suggestive of a cell clone harboring a replication-competent provirus. No intact proviruses were detected in four children who initiated ART before 2.3 months of age. Rare, intact proviruses can be detected in children who initiate ART after 2.3 months of age and are probably, as in adults, maintained by clonal expansion of cells infected before ART initiation.IMPORTANCE There are limited data about the proviral landscape in children exhibiting long-term suppression after early treatment, particularly in Sub-Saharan Africa where HIV-1 subtype C predominates. Investigating the sequence-intact reservoir could provide insight on the mechanisms by which intact proviruses persist and inform ongoing cure efforts. Through nearly full-length proviral amplification and sequencing (NFL-PAS), we generated 733 NFL-PAS amplicons from eight children. We showed that rare, genetically intact proviruses could be detected in children who initiated ART after 2.3 months of age. The frequency of intact proviruses was lower (P < 0.05) than that reported for HIV subtype B-infected adults treated during early HIV infection. We show that cells harboring genetically intact HIV proviruses are rare in children exhibiting long-term suppression after early treatment and may require the processing of a large number of cells to assess reservoir size. This points to the need for efficient methods to accurately quantify latent reservoirs, particularly in pediatric studies where sample availability is limited.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  HIV cure; HIV early ART children; HIV full-length sequencing; HIV intact provirus; HIV persistence; HIV persistence children; HIV proviral landscape; HIV reservoir; HIV reservoir decay; human immunodeficiency virus

Mesh:

Substances:

Year:  2020        PMID: 31776265      PMCID: PMC6997763          DOI: 10.1128/JVI.01519-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.

Authors:  Radjin Steingrover; Katalyn Pogány; Evian Fernandez Garcia; Suzanne Jurriaans; Kees Brinkman; Hanneke Schuitemaker; Frank Miedema; Joep Ma Lange; Jan M Prins
Journal:  AIDS       Date:  2008-08-20       Impact factor: 4.177

2.  Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure.

Authors:  V Miller; C Sabin; K Hertogs; S Bloor; J Martinez-Picado; R D'Aquila; B Larder; T Lutz; P Gute; E Weidmann; H Rabenau; A Phillips; S Staszewski
Journal:  AIDS       Date:  2000-12-22       Impact factor: 4.177

3.  Novel Assays for Measurement of Total Cell-Associated HIV-1 DNA and RNA.

Authors:  Feiyu Hong; Evgenia Aga; Anthony R Cillo; Aarika L Yates; Guillaume Besson; Elizabeth Fyne; Dianna L Koontz; Cheryl Jennings; Lu Zheng; John W Mellors
Journal:  J Clin Microbiol       Date:  2016-01-13       Impact factor: 5.948

4.  Rapid viral rebound after 4 years of suppressive therapy in a seronegative HIV-1 infected infant treated from birth.

Authors:  Karina M Butler; Patrick Gavin; Suzie Coughlan; Annette Rochford; Sinead Mc Donagh; Orla Cunningham; Hannah Poulsom; Sarah A Watters; Nigel Klein
Journal:  Pediatr Infect Dis J       Date:  2015-03       Impact factor: 2.129

5.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

6.  Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane.

Authors:  Zheng Wang; Evelyn E Gurule; Timothy P Brennan; Jeffrey M Gerold; Kyungyoon J Kwon; Nina N Hosmane; Mithra R Kumar; Subul A Beg; Adam A Capoferri; Stuart C Ray; Ya-Chi Ho; Alison L Hill; Janet D Siliciano; Robert F Siliciano
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-26       Impact factor: 11.205

7.  Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo.

Authors:  Francesco R Simonetti; Michele D Sobolewski; Elizabeth Fyne; Wei Shao; Jonathan Spindler; Junko Hattori; Elizabeth M Anderson; Sarah A Watters; Shawn Hill; Xiaolin Wu; David Wells; Li Su; Brian T Luke; Elias K Halvas; Guillaume Besson; Kerri J Penrose; Zhiming Yang; Richard W Kwan; Carter Van Waes; Thomas Uldrick; Deborah E Citrin; Joseph Kovacs; Michael A Polis; Catherine A Rehm; Robert Gorelick; Michael Piatak; Brandon F Keele; Mary F Kearney; John M Coffin; Stephen H Hughes; John W Mellors; Frank Maldarelli
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

8.  Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size.

Authors:  Vivek Jain; Wendy Hartogensis; Peter Bacchetti; Peter W Hunt; Hiroyu Hatano; Elizabeth Sinclair; Lorrie Epling; Tzong-Hae Lee; Michael P Busch; Joseph M McCune; Christopher D Pilcher; Frederick M Hecht; Steven G Deeks
Journal:  J Infect Dis       Date:  2013-07-12       Impact factor: 5.226

9.  Paucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection.

Authors:  Kaitlin Rainwater-Lovett; Carrie Ziemniak; Douglas Watson; Katherine Luzuriaga; George Siberry; Ann Petru; YaHui Chen; Priyanka Uprety; Margaret McManus; Ya-Chi Ho; Susanna L Lamers; Deborah Persaud
Journal:  PLoS One       Date:  2017-02-08       Impact factor: 3.240

10.  A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation.

Authors:  Avy Violari; Mark F Cotton; Louise Kuhn; Diana B Schramm; Maria Paximadis; Shayne Loubser; Sharon Shalekoff; Bianca Da Costa Dias; Kennedy Otwombe; Afaaf Liberty; James McIntyre; Abdel Babiker; Diana Gibb; Caroline T Tiemessen
Journal:  Nat Commun       Date:  2019-01-24       Impact factor: 14.919

View more
  11 in total

Review 1.  The HIV-1 antibody response: a footprint of the viral reservoir in children vertically infected with HIV.

Authors:  Paolo Palma; Margaret McManus; Nicola Cotugno; Salvatore Rocca; Paolo Rossi; Katherine Luzuriaga
Journal:  Lancet HIV       Date:  2020-05       Impact factor: 12.767

2.  Systemic and Intestinal Viral Reservoirs in CD4+ T Cell Subsets in Primary SIV Infection.

Authors:  Xiaolei Wang; Widade Ziani; Ronald S Veazey; Huanbin Xu
Journal:  Viruses       Date:  2021-11-30       Impact factor: 5.048

Review 3.  New Approaches to Multi-Parametric HIV-1 Genetics Using Multiple Displacement Amplification: Determining the What, How, and Where of the HIV-1 Reservoir.

Authors:  Sean C Patro; Aurelie Niyongabo; Frank Maldarelli; Mary F Kearney
Journal:  Viruses       Date:  2021-12-10       Impact factor: 5.048

Review 4.  The Clonal Expansion Dynamics of the HIV-1 Reservoir: Mechanisms of Integration Site-Dependent Proliferation and HIV-1 Persistence.

Authors:  Yang-Hui Jimmy Yeh; Kerui Yang; Anya Razmi; Ya-Chi Ho
Journal:  Viruses       Date:  2021-09-17       Impact factor: 5.818

5.  NanoHIV: A Bioinformatics Pipeline for Producing Accurate, Near Full-Length HIV Proviral Genomes Sequenced Using the Oxford Nanopore Technology.

Authors:  Imogen A Wright; Kayla E Delaney; Mary Grace K Katusiime; Johannes C Botha; Susan Engelbrecht; Mary F Kearney; Gert U van Zyl
Journal:  Cells       Date:  2021-09-28       Impact factor: 6.600

Review 6.  Understanding Viral and Immune Interplay During Vertical Transmission of HIV: Implications for Cure.

Authors:  Omayma Amin; Jenna Powers; Katherine M Bricker; Ann Chahroudi
Journal:  Front Immunol       Date:  2021-10-21       Impact factor: 7.561

7.  Persistence of Unintegrated HIV DNA Associates With Ongoing NK Cell Activation and CD34+DNAM-1brightCXCR4+ Precursor Turnover in Vertically Infected Patients Despite Successful Antiretroviral Treatment.

Authors:  Lucia Taramasso; Federica Bozzano; Anna Casabianca; Chiara Orlandi; Francesca Bovis; Sara Mora; Mauro Giacomini; Lorenzo Moretta; Mauro Magnani; Antonio Di Biagio; Andrea De Maria
Journal:  Front Immunol       Date:  2022-04-26       Impact factor: 8.786

Review 8.  Residual Proviral Reservoirs: A High Risk for HIV Persistence and Driving Forces for Viral Rebound after Analytical Treatment Interruption.

Authors:  Xiaolei Wang; Huanbin Xu
Journal:  Viruses       Date:  2021-02-21       Impact factor: 5.048

Review 9.  HIV-1 Persistence in Children during Suppressive ART.

Authors:  Mary Grace Katusiime; Gert U Van Zyl; Mark F Cotton; Mary F Kearney
Journal:  Viruses       Date:  2021-06-12       Impact factor: 5.048

10.  Simian-Human Immunodeficiency Virus SHIV.C.CH505 Persistence in ART-Suppressed Infant Macaques Is Characterized by Elevated SHIV RNA in the Gut and a High Abundance of Intact SHIV DNA in Naive CD4+ T Cells.

Authors:  Veronica Obregon-Perko; Katherine M Bricker; Gloria Mensah; Ferzan Uddin; Mithra R Kumar; Emily J Fray; Robert F Siliciano; Nils Schoof; Anna Horner; Maud Mavigner; Shan Liang; Thomas Vanderford; Julian Sass; Cliburn Chan; Stella J Berendam; Katharine J Bar; George M Shaw; Guido Silvestri; Genevieve G Fouda; Sallie R Permar; Ann Chahroudi
Journal:  J Virol       Date:  2020-12-22       Impact factor: 6.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.